03 November 1997
Med Sci Monit 1997; 3(6): CR895-903 :: ID: 501828
The aim of the study was an assessment of the disorders in calcium and phosphorus balance in children participating in the program of repeated haemodialyses (HD) as well as a continuous ambulatory peritoneal dialysis (CAPD). 29 patients - aged 3 to 20 (mean age 11) - were included in the study; 18 of them received HD and 11 were treated with CAPD. All patients were given alphacalcidol at the dose of 0.005 to 0.023 µg/kg/24 hours and CaCO3 at the dose of 50-200 mg/kg/24 hours. The patients from both groups (HD and CAPD) did not differ from each other with respect to their age, the time of dialysis and the dose of CaCO3. The dose of alphacalcidol was significantly higher in the group treated with CAPD. Every 4 months, patientsÕ serum was examined to determine the concentration of the following: Ca, P, parathormone (PTH int), alkaline phosphatase (AP), osteocalcin (OC) and procollagen IC (PICP). In the group of peritoneally dialysed children we found lower concentrations of phosphorus and PTH int, and higher AP activity. Low concentrations of PTH were found in 60% of patients from both groups, which in 54% of cases were accompanied by low bone metabolism markers. The number of hypercalcaemia episodes equalled 17% in HD patients and 15% in the group with CAPD. The concentrations P>3.5 mEq/l were found in 40% of tests in HD group and in 17.7% of tests in CAPD patients. Hypercalcaemia episodes did not last long and they did not cause clinical problems. Increased P concentrations resulted either from inappropriate diet or not taking CaCO3 at the time of meals. The application of alphacalcidol and CaCO3 effectively prevents the development of hyperparathyroidism in the course of chronic renal failure, although the simultaneous use of high calcium concentration may result in the development of osteopathy with decreased bone turnover. A systematic determination of the concentration of Ca, P, PTH int and a selected bone metabolism marker is necessary for the evaluation of bone metabolism in children undergoing dialysis.
Keywords: renal osteodystrophy, Calcium Carbonate, alphacalcidol, bone metabolism markers
This Week Editorial
20 September 2021 : EditorialEditorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19
Med Sci Monit 2021; 27:e934766
22 September 2021 : EditorialEditorial: Global Regulatory Initiatives Deliver Accelerated Approval of the First Bispecific Therapeutic M...
Med Sci Monit In Press; DOI: 10.12659/MSM.934854
08 September 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit In Press; DOI: 10.12659/MSM.932788
16 July 2021 : Review articleSilent Hypoxemia in Patients with COVID-19 Pneumonia: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.930776
24 Sep 2021 : Clinical ResearchA Single-Center Study of a Resin Inlay Dental Implant-Fixed Prosthesis for Closing Proximal Contact Loss in...
Med Sci Monit In Press; DOI: 10.12659/MSM.933809
24 Sep 2021 : Database AnalysisRelationships Between Obstructive Sleep Apnea and Cardiovascular Disease: A Bibliometric Analysis (2010-2021)
Med Sci Monit In Press; DOI: 10.12659/MSM.933448
24 Sep 2021 : Database AnalysisA Statistical Prediction Model for Survival After Kidney Transplantation from Deceased Donors
Med Sci Monit In Press; DOI: 10.12659/MSM.933559
20 Mar 2020 : Clinical ResearchSocial Capital and Sleep Quality in Individuals Who Self-Isolated for 14 Days During the Coronavirus Diseas...
Med Sci Monit 2020; 26:e923921
15 Apr 2020 : Clinical ResearchPsychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 20...
Med Sci Monit 2020; 26:e924171
05 May 2020 : Review articleAn Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
Med Sci Monit 2020; 26:e924700